Market access and health technology assessment

A reader chooses here between the two sides of deciding on a population's care and what is paid for in it: the economic and assessment evidence such decisions rest on, or the documents in which a product's value is argued and decided for those who pay for care. It leaves the marketing-authorisation dossier filed before either to marketing authorisation, the statistics an economic argument draws on to statistics, working beside a health economist to working with health economists, and promoting the product to prescribers to promotion and its rules.

• Health economics and technology assessment — what health technology assessment is and where it came from, health economic evaluation, what each step of an assessment produces for publication, communicating its uncertainty, how practice differs between countries, how the pandemic and real-world evidence are changing it, and the ethics of assessment
• Value and reimbursement documents — health technology assessment submissions, Germany's early benefit assessment dossiers, US formulary dossiers, health economic reports, and the guidance an assessment body publishes